研究文章
实证研究安全风险信息的透明度在中国上市医药企业基于ANP-DS方法
|
| B |
B1 |
B2 |
B3 |
B4 |
B5 |
B6 |
B7 |
B8 |
B9 |
当地的重量 |
|
| B1 |
1 |
3 |
2 |
1 |
|
|
|
|
|
0.351 |
| B2 |
1/3 |
1 |
2 |
3 |
|
|
|
|
|
0.110 |
| B3 |
1/2 |
1/2 |
1 |
2 |
|
|
|
|
|
0.189 |
| B4 |
1 |
1/3 |
1/2 |
1 |
|
|
|
|
|
0.351 |
| B5 |
|
|
|
|
1 |
1 |
2 |
2 |
2 |
0.277 |
| B6 |
|
|
|
|
1 |
1 |
2 |
3 |
3 |
0.328 |
| B7 |
|
|
|
|
1/2 |
1/2 |
1 |
1 |
1 |
0.139 |
| B8 |
|
|
|
|
1/2 |
1/3 |
1 |
1 |
1 |
0.128 |
| B9 |
|
|
|
|
1/2 |
1/3 |
1 |
1 |
1 |
0.128 |
|
|
